Nicolás Kreplak, the health minister for the Province of Buenos Aires, said the worst phase of the COVID-19 pandemic has ended in the region [1].
The announcement signals a transition in the province's public health strategy, moving from emergency crisis management toward long-term research and regulatory improvement. This shift is intended to stabilize the healthcare system after years of pandemic-driven strain.
Kreplak said vaccination efforts played a role in achieving this milestone. He noted that more than 60% of the population has received at least one dose of a COVID-19 vaccine [2]. This coverage provided the necessary foundation for the province to reduce the severity of outbreaks and lower the pressure on hospital infrastructure.
Beyond vaccination, the health ministry has focused on enhancing medical research and updating health regulations. These efforts recently earned a special mention from the Cámara Argentina de Especialidades Medicinales, known as CAEME [1]. The organization said the keys to the recognition were the initiatives to boost research and improve health regulations [1].
Kreplak said, "Ya pasó lo peor de la pandemia en la provincia de Buenos Aires" [2]. The minister said the current focus is on maintaining these gains through systemic improvements to the provincial health framework.
The recognition from CAEME underscores a broader effort to integrate academic research into public health policy. By streamlining regulations, the province aims to accelerate the implementation of new medical treatments and preventative measures, a strategy the ministry believes is essential for future pandemic preparedness.
“"Ya pasó lo peor de la pandemia en la provincia de Buenos Aires."”
The declaration that the worst of the pandemic has passed reflects a shift toward 'post-pandemic' governance in Buenos Aires. By emphasizing vaccination rates and regulatory reform, the provincial government is attempting to pivot from reactive emergency measures to a proactive health infrastructure. The CAEME recognition suggests an increasing reliance on public-private partnerships to modernize medical research and oversight in Argentina.
